Back to Results
First PageMeta Content
Addiction psychiatry / Drug addiction / Morphinans / Euphoriants / Substance dependence / Drug Addiction Treatment Act / Buprenorphine / Opioid dependence / Methadone / Chemistry / Drug rehabilitation / Organic chemistry


SAMHSA Determinations Report
Add to Reading List

Document Date: 2009-04-15 16:27:55


Open Document

File Size: 47,54 KB

Share Result on Facebook

City

Rockville / /

Company

Roxane Laboratories / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

insurance coverage / treatment of substance use disorders / insurance / information to guide data systems / law enforcement / generic products / /

MedicalCondition

substance use disorders / heroin abuse / Drug Abuse / opiate addiction / cardiac arrest / heroin dependence / /

Organization

Center for Substance Abuse Treatment / American Psychiatric Association / U.S. Department of Health and Human Services / National Drug Intelligence Center / SAMHSA’s office of Applied Studies / American Osteopathic Association / Food and Drug Administration / American Academy of Addiction Psychiatry / American Medical Association / National Institute on Drug Abuse / American Society of Addiction Medicine / Substance Abuse and Mental Health Services Administration / Department of Justice / Drug Enforcement Administration / /

Person

Clinton / /

Position

President / Physician / Secretary / /

Product

Suboxone / ORLAAM / Subutex / V / Suboxone® / /

ProvinceOrState

Maryland / /

PublishedMedium

Public Law / /

Technology

alpha / medical diagnostic / /

SocialTag